About AccuFix Surgical

AccuFix was founded by a team of veteran healthcare executives with over 300 years of combined industry experience. The company holds six active patents and two trademarks, focusing on minimally invasive solutions that prioritize "bone-sparing" techniques for long-term patient health.

Discover the future of orthopedic surgery with AccuFix Surgical. In this exclusive interview with the Global Investment Leaders Club, the team shares their FDA-cleared solution for Hallux Rigidus, designed to preserve natural joint anatomy and restore active lifestyles.

With 300+ successful implants, AccuFix’s patented AccuJoint removes just 1 mm of bone, offering improved mobility and pain reduction compared to traditional treatments.

Highlights:

 • Breakthrough bone-sparing technology
 • Strong clinical outcomes within 12 months
 • $9B market opportunity & growth strategy
 • $4.3M raised and ongoing expansion

Speakers:

John K. Evans (CEO), Dr. Aaron Shemenski (CMO), Jamie Lineberger (Co-Chairman)